|
Akio T, Carol PG, Richard RA, Stephen KA, Hsing-Jien K, and Donald JF. (1987) DNA sequence encoding the amino-terminal region of the human c-src protein : implications of sequence divergence among src-type kinase oncogenes. Mol Cell Biol. 7, 1978- 1983. Amphawan A, Nongnuch V, and Duang B. (1995) Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethno- pharmacology. 49, 163-169. Andrew EA, Alan KH , and RL J. (1999) Cell adhesion molecules, signal transduction and cell growth. Current Opinion Cell Biol. 11,737—744. Anja S, Emmanuelle C, and Allan H. (2001) Lipopolysaccharide-induced activation of β2-integrin function in macrophages requires Irak kinase activity, p38 mitogen-activated protein kinase, and the Rap1 GTPase. Mol Cell Biol. 21, 438-448. Anna R, Kira S, Elena M, Ernst-Dietrich K, Armand T, and Alexander T. (1999) Phosphorylation of p125FAK and paxillin focal adhesion proteins in src-transformed cells with different metastatic capacity. FEBS Lett. 455, 145-148. Anoop KS, Gurmel SS, Deepa T, and Radha KM. (1996) Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. Cancer Lett. 107, 109-115. Aplin AE, Howe A, Alahari SK, and Juliano RL. (1998) Signal transduction and signal modulation by cell adhesion receptors : the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Therapeut. 50, 197-263. Cai H, Jiali L, Christian CH, and Xi Z. (1998) The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Boil Chem. 273, 25770-25776. Carla JC. (1999) New insights into the role of serum amyloid P component, a novel lipopolysaccharide-binding protein. FEMS Immunol Med Mic. 26, 197-202. Christian J, Cynthia AB, Maria PR, Booker J, Acharan SN, David AB, and Balfour S. (1999) Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-kB kinase activity. The J Immuno. 163, 3474-3483. Christof RH, Datsun AH, and David DS. (2000) Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J Boil Chem. 275, 41092-41099. Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, and Cheng AL. (2000) Curcumin-containing diet inhibits diethyl- nitrosamine induced murine hepatocarcinogenesis. Carcinogenesis 21, 331-335. Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS, Laskin JD, and Huang MT. (1991) Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul. 31, 385-389. Cross FR, Garber EA, and Hanafusa H. (1985) N-terminal deletions in rous sarcoma virus p60Src : effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene. Mol Cell Biol. 5, 2789-2795. Huang MT, Lou YR, Ma W, Newmark LH, Reuhl KR and Conney AH. (1994) Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 54, 5841—5847. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, and Conney AH. (1991) Inhibitory effects of curcumin in vivo lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51,813-819. Huang MT, Ma W, Lu YP, Chang RL, Fischer C, Manchand PS, Newmark HL, and Conney AH. (1995) Effect of curcumin, demethoxycurcumin, bisdemethoxy-curcumin and tetrahydrocurcumin on TPA-induced tumor promotion. Carcinogenesis 16, 2493-2497. Huang MT, Smart RC, Wong CQ, and Conney AH. (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48, 5941-5946. Huang MT, Wang ZY, Georgiadis CA, Laskin JD, and Conney AH. (1992) Inhibitory effect of curcumin on tumor initiation by benzo [a]pyrene and 7,12-dimethyl-benz[a]anthracene. Carcinogenesis 13, 947-954. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T, and Aizawa S. (1995) Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544. Jiang MC, Yang-Yen HF, Yen JJ, and Lin JK. (1996) Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer. 26, 111-120. Jen-Kun L, and Shoei-Yn LS. (2001) Mechanisms of cancer chemoprevention by curcumin. Proc. Natl. Sci. Counc. ROC(B). 25, 59-66. Jones RJ, Brunton VG, and Frame MC. (2000) Adhesion-linked kinases in cancer; emphasis on Src, focal adhesion kinase and PI 3-kinase. Eur J Cancer. 36, 1595-1606. Keith S, Christopher MD, Matthew W, and Carolyn F. (1996) Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett. 103, 137-141 Klemke R, Leng J, Molander R, Brooks P, Vuori K, and Cheresh D. CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. (1998) J Cell Biol. 140, 961-972. Knirel YA. (1990) Polysaccharide antigens of Pseudomonas aeruginosa. Crit Rev Microbiol. 17, 273-304. Kodi SR. (2001) Signaling via Shc family adapter proteins. Oncogene 20, 6322-6330. Kunchandy E, and Rao MNA. (1990) Oxygen radical scavenging activity of curcumin. Int'l J Pharm. 38, 239-240 Lata GM, Ramadasan K, Girija K. (1999) Anti-metastatic activity of curcumin and catechin. Cancer Lett. 141, 159-165. Lin JK, Chen YC, Huang YT, and Lin-Shiau SY. (1997) Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J Cell Biochem. 28/29, 39-48. Luigina F, and Denise D. (1998) Nitric oxide enhances prostaglandin production in ethanol-induced gastric mucosal injury in rats. Euro J Pharmacology. 348, 247-256. Lu YP, Chang RL, Lou YR, Huang MT, Newmark HL, Reuhl KR, and Conney AH. (1994) Effect of curcumin on 12-O-tetradecanoylphorbol- 13-acetate and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. Carcinogenesis 15, 2363-2370. Lutz H, Volker EL-S, Artur JU, Hans-Dieter F, and Ernst TR. (1998) Components of gut bacteria as immunomodulators. Inter J Food Microbiology. 41, 141-154. Marc DB, Irvin MM, and Joseph AM. (1992) Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J Clin Invest. 90, 15-23. Marcia AW, Jeong HY, Leif EO, and Robert MW. (2001) Cyclooxygenase-2 protein and prostaglandin E2 production are up-regulated in a rat bladder inflammation model. Euro J Pharmacology. 417, 239-248. Margaret MM, Andreas G,Hudson EA, Simon MP, Matthew SS, and Sally AP. (2000) Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicology Lett. 112—113, 499—505. Mary TC, Stacey LH, and Anthony LD. (1996) Activation-induced association of a 145-kDa tyrosine-phosphorylated protein with Shc and Syk in B lymphocytes and macrophages. J Boil Chem. 270, 6824-6829. Masayuki K, Takashi M, Kenji I, Akihiko U, Yasuo M, Mitsuo K, and Masao T. (2000) Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activation. Oncogene 19, 1225-1231. Mazumder A, Raghavan K, Weinstein J, Kohn KW, and Pommier Y. (1995) Inhibition of HIV-1 integrase by curcumin. Biochem Pharm. 49, 1165-1170. McMahon SB, and Monroe J. (1996) The role of early growth response gene-1 (egr-1) in regulation of the immune response. J Leukoc Biol. 60, 159—66. Megan TB, and Jonathan AC. (1996) Regulation, substrates and functions of src. BBA. 1287,121-149. Michael DS. (2001) Biochemical signals and biological responses elicited by the focal adhesion kinase. BBA. 1540, 1-21. Michael JW. (2001) Colon cancer chemoprevention with ginseng and other botanicals. J Korean Med Sci. 16, S81-S86. Min-Hsiung P, Shoei-Yn LS and Jen-Kun L. (2000) Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IκB Kinase and NFκB activation in Macrophages. Biochem Pharmacol. 60, 1665—1676. Mushtaq A, Pandora T, and Russell MM. (1998) Role of activating Protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-α. J Biol Chem. 267, 16323-16329. Otto H, Artur JU, Helmut B, Hans-Dieter F, Ernst TR. (1996) Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med Mic. 16, 83-104. Peter BJ, and Tony H. (2001) Oncogenic kinase signaling. Nature 411, 355- 365. Rajeshwari M, Susan LS, Ya L, and Salman A. (2001) Impaired activation of AP-1 and altered expression of constituent proteins in rat adrenal during ageing. Mech Ageing Dev. 122, 1169-1186. Rao CV, Rivenson A, Simi B and Reddy BS. (1995) Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55, 259—266. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F, Schreier M, and Brade H. (1994) Bacterial endotoxin : molecular relationships of structure to activity and function. FASEB J. 218, 217-225. Roberto M, Roberta F, Rekha B, and COLIN JG. (2000) Curcumin, an antioxidant and anti-inflammatory agent, indues heme oxyganase-1 and protects endothelial cells against oxidative stress. Free Radical Bio Med. 28, 1303—1312, 2000. Rosenberg L, Louik C, and Shapiro S. (1998) Nonsteroidal anti- inflammatory drug use and reduced risk of large bowel carcinoma. Cancer 82, 2326-2333. Ruby JA, Tessy TM, and Devarajan K. (2000) L-929 Cells harboring ectopically expressed RelA resist curcumin-induced apoptosis. J Biol Chem. 275, 15601-15604. Ruey-Long H, William HS, and Mien-Chie H. (1999) Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu1. Clin Cancer Res. 5, 1884-1891. Sanjaya S, and Bharat BA. (1995) Activation of transcription factor NF-κB Is suppressed by curcumin (diferulolylmethane). J Biol Chem. 270, 24995- 25000. Scott D, Mary-Anne S, and Keith B. (2001) SRC transcriptional activation in a subset of human colon cancer cell lines. FEBS Lett. 487, 367-371. Shih CA, and Lin, JK. (1993) Inhibition of 8-hydroxydeoxyguanosine formation by curcumin in mouse fibroblast cells. Carcinogenesis 14, 709-712. Stehelin D, Varmus HE, Bishop JM, and Vogt PK. (1976) DNA related to the transforming gene(s) of avian sarcoma virus is present in normal avian DNA. Nature (London) 260, 170-173. Sui Z, Salto R, Li J, Craik C, and Ortiz de Montellano PR. (1993) Inhibition of HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem. 1, 415-422. Tammy LK, and Frank B. (1995) CD14 and other recognition molecules for lipopolysaccharide : a review. Immunopharmacology 29, 187-205. Tang-Long S, and Jun-Lin G. (2001) Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts. FEBS Lett. 499, 176-181. Toshihiko K, Ronald L, Vernon ES, Gary JK, Robert BK, Chinthalapally V Rao, and Bandaru SR. (1999) Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/ progression stages of colon cancer. Cancer Res. 59, 597—601. Toshiya M, Kayo H, Ayumi Shinohara, Tomomi Maekawa, Yoshio Takeda, and Hidemasa Y. (1999) Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcumin. J Agric Food Chem. 47, 71-77. Usha RP, and Vijaya MR. (2000) Suppression of transcription factor Egr-1 by curcumin. Thrombosis Res. 97, 179-189. Verde P, Boast S, Franze A, Robbiati F, and Blasi F. (1998) An upstream enhancer and a negative element in the 5’ flanking region of the human urokinase plasminogen activator gene. Nucleic Acids Res. 16, 10699—716. Wang LH, Halpern CC, Nadel M, and Hanafusa H. (1978) Recombination between viral and cellular sequences generates transforming sarcoma viruses. Proc Natl Acad Sci USA. 75, 5812-5816. Wan-Jr S, Chien-Chang S, Ming-Jaw D, Jun-Chih O, Gene-Hsiang L, and Chang-Ming S. (1998) Cytotoxicity of curcuminoids and some novel compounds from Curcuma zedoaria. J Nat Prod. 61, 1531-1534. Wargovich MJ, Chen CD, Harris C, Yang E, and Velasco M. (1995) Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int J Cancer. 60, 515-519. Wargovich MJ, Jimenez A, McKee K, Steele VE, Velasco M, Woods J, Price R, Gray K, and Kelloff GJ. (2000) Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 21, 1149-1155. Yan-Shi G, Mark RH, Xiao DW, and Courtney MT Jr. (2001) Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase -2 expression in intestinal epithelial cells. J Biol Chem. 276, 22941-22947. Young-Joon S, Kyung-Soo C, Hyun-Ho C, Seong SH, Young-Sam K, Kwang-Kyun P,and Sang SL. (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down- regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutation Res. 480—481, 243—268.
|